Jaguar Health, Inc. (JAGX)
0.5858
-0.02
(-3.49%)
USD |
NASDAQ |
Feb 12, 16:00
0.5982
+0.01
(+2.12%)
After-Hours: 20:00
Jaguar Health Cash from Investing (Quarterly) : -0.054M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 1.297M |
| Geron Corp. | 13.35M |
| Corvus Pharmaceuticals, Inc. | -2.618M |
| Rapt Therapeutics, Inc. | 8.466M |
| Recursion Pharmaceuticals, Inc. | -2.549M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.689M |
| Cash from Financing (Quarterly) | 6.259M |
| Free Cash Flow | -26.29M |
| Free Cash Flow Per Share (Quarterly) | -3.134 |
| Free Cash Flow to Equity (Quarterly) | -6.113M |
| Free Cash Flow to Firm (Quarterly) | -4.737M |
| Free Cash Flow Yield | -1.10K% |